LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Suchergebnis

Treffer 1 - 10 von insgesamt 61

Suchoptionen

  1. Buch ; Online: The European Blood and Marrow Transplantation Textbook for Nurses

    Kenyon, Michelle / Babic, Aleksandra

    Under the Auspices of EBMT

    2023  

    Verfasserangabe edited by Michelle Kenyon, Aleksandra Babic
    Schlagwörter Nursing ; Transplantation of organs, tissues, etc ; Surgery ; Children—Surgery
    Sprache Englisch
    Umfang 1 Online-Ressource (X, 331 p. 38 illus., 29 illus. in color)
    Ausgabenhinweis 2nd ed. 2023
    Verlag Springer International Publishing ; Imprint: Springer
    Erscheinungsort Cham
    Dokumenttyp Buch ; Online
    HBZ-ID HT030005270
    ISBN 978-3-031-23394-4 ; 9783031233937 ; 9783031233951 ; 3-031-23394-8 ; 303123393X ; 3031233956
    DOI 10.1007/978-3-031-23394-4
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Zusatzmaterialien

    Kategorien

  2. Buch ; Online: The European Blood and Marrow Transplantation Textbook for Nurses

    Kenyon, Michelle / Babic, Aleksandra

    Under the Auspices of EBMT

    2023  

    Schlagwörter Nursing ; Transplant surgery ; Surgery ; General surgery ; Haematopoietic Stem Cell Transplant ; Nursing care ; Cell Therapy ; Paediatric transplant nursing ; Apheresis
    Sprache Englisch
    Umfang 1 electronic resource (331 pages)
    Verlag Springer Nature
    Erscheinungsort Cham
    Dokumenttyp Buch ; Online
    Anmerkung English
    HBZ-ID HT030378032
    ISBN 9783031233937 ; 303123393X
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Zusatzmaterialien

    Kategorien

  3. Buch ; Online: The European Blood and Marrow Transplantation Textbook for Nurses

    Kenyon, Michelle / Babic, Aleksandra

    Under the Auspices of EBMT

    2018  

    Verfasserangabe edited by Michelle Kenyon, Aleksandra Babic
    Schlagwörter Medicine ; Blood transfusion ; Hematology ; Nursing ; Pediatric surgery ; Surgical transplantation ; Surgical oncology
    Thema/Rubrik (Code) 610.73
    Sprache Englisch
    Umfang 1 Online-Ressource (XVII, 311 p. 48 illus., 36 illus. in color)
    Verlag Springer International Publishing ; Imprint: Springer
    Erscheinungsort Cham
    Dokumenttyp Buch ; Online
    HBZ-ID HT019641384
    ISBN 978-3-319-50026-3 ; 9783319500256 ; 3-319-50026-0 ; 3319500252
    DOI 10.1007/978-3-319-50026-3
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Zusatzmaterialien

    Kategorien

  4. Buch ; Online: The European Blood and Marrow Transplantation Textbook for Nurses: Under the Auspices of EBMT

    Babic, Aleksandra / Kenyon, Michelle

    2018  

    Schlagwörter Nursing care ; Paediatric transplant nursing ; Apheresis ; Haemato-oncology nursing ; Haematopoietic Stem Cell Transplant
    Umfang 1 electronic resource (311 pages)
    Verlag Springer Nature
    Dokumenttyp Buch ; Online
    Anmerkung English ; Open Access
    HBZ-ID HT021043493
    ISBN 9783319500256 ; 3319500252
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Analysis of non-mutagenic substances in the context of drug impurity assessment - Few are potent toxicants.

    Hasselgren, Catrin / Kenyon, Michelle / Anger, Lennart T / Cornwell, Paul / Watt, Eric / Bercu, Joel

    Regulatory toxicology and pharmacology : RTP

    2024  Band 150, Seite(n) 105645

    Abstract: ICH Q3A/B guidelines provide qualification thresholds for impurities or degradation products in new drug substances and products. However, the guidelines note that certain impurities/degradation products may warrant further safety evaluation for being ... ...

    Abstract ICH Q3A/B guidelines provide qualification thresholds for impurities or degradation products in new drug substances and products. However, the guidelines note that certain impurities/degradation products may warrant further safety evaluation for being unusually potent or toxic. The purpose of this study was to confirm that especially toxic non-mutagenic compounds are rare and to identify classes of compounds that could warrant lower qualification thresholds. A total of 2815 compounds were evaluated, of which 2213 were assessed as non-mutagenic. For the purpose of this analysis, compounds were considered potent when the point of departure was ≤0.2 mg/kg/day based on the qualification threshold (1 mg/day or 0.02 mg/kg/day for a 50 kg human) in a new drug substance, with an additional 10-fold margin. Only 54 of the entire set (2.4%) would be considered potent based on this conservative potency analysis, confirming that the existing ICH Q3A/B qualification thresholds are appropriate for the majority of impurities. If the Q3A/B threshold, without the additional 10-fold margin is used, 14 compounds (0.6%) are considered "highly potent". Very few non-mutagenic structural classes were identified, including organothiophosphates and derivatives, polychlorinated benzenes and polychlorinated polycyclic aliphatics, that correlate with potential high potency, consistent with prior publications.
    Sprache Englisch
    Erscheinungsdatum 2024-05-16
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 604672-1
    ISSN 1096-0295 ; 0273-2300
    ISSN (online) 1096-0295
    ISSN 0273-2300
    DOI 10.1016/j.yrtph.2024.105645
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: Global collaboration led by the EBMT Nurses Group.

    Trigoso, Eugenia / Ruiz, Julia / Kenyon, Michelle / Murray, John

    The Lancet. Haematology

    2021  Band 8, Heft 6, Seite(n) e396–e397

    Mesh-Begriff(e) Asia ; Bone Marrow Transplantation/nursing ; Bone Marrow Transplantation/standards ; Education, Nursing, Continuing/organization & administration ; Europe ; Evidence-Based Nursing/organization & administration ; Global Health ; Hematopoietic Stem Cell Transplantation/nursing ; Hematopoietic Stem Cell Transplantation/standards ; Humans ; International Cooperation ; Latin America ; Nurse's Role ; Quality Control ; Societies, Nursing/organization & administration
    Sprache Englisch
    Erscheinungsdatum 2021-05-11
    Erscheinungsland England
    Dokumenttyp Journal Article
    ISSN 2352-3026
    ISSN (online) 2352-3026
    DOI 10.1016/S2352-3026(21)00133-2
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Deriving acceptable limits for non-mutagenic impurities in medicinal products - Durational adjustments.

    Kenyon, Michelle O / Martin, Matthew / Martin, Elizabeth A / Brandstetter, Susanne / Wegesser, Teresa / Greene, Nigel / Harvey, James

    Regulatory toxicology and pharmacology : RTP

    2024  Band 150, Seite(n) 105644

    Abstract: ICH Q3A/B guidelines are not intended for application during the clinical research phase of development and durationally adjusted qualification thresholds are not included. A central tenet of ICH Q3A is that lifetime exposure to 1 mg/day of an ... ...

    Abstract ICH Q3A/B guidelines are not intended for application during the clinical research phase of development and durationally adjusted qualification thresholds are not included. A central tenet of ICH Q3A is that lifetime exposure to 1 mg/day of an unqualified non-mutagenic impurity (NMI) is not a safety concern. An analysis of in vivo toxicology data from 4878 unique chemicals with established NO(A)ELs was conducted to determine whether durationally adjusted qualification limits can be supported. Although not recommended in ICH Q3A/B, a conservative approach was taken by using allometric scaling in the analysis. Following allometric scaling of the 5th percentile of the distribution of NO(A)ELs from available chronic toxicology studies, it was reconfirmed that there is a safety basis for the 1 mg/day qualification threshold in ICH Q3A. Additionally, allometric scaling of the 5th percentile of the distribution of NO(A)ELs from sub-acute and sub-chronic toxicology studies could support acceptable limits of 20 and 5 mg/day for an unqualified NMI for dosing durations of less than or greater than one month, respectively. This analysis supports durationally adjusted NMI qualification thresholds for pharmaceuticals that protect patient safety and contribute to 3Rs efforts for qualifying impurities using new approach methods.
    Sprache Englisch
    Erscheinungsdatum 2024-05-16
    Erscheinungsland Netherlands
    Dokumenttyp Journal Article
    ZDB-ID 604672-1
    ISSN 1096-0295 ; 0273-2300
    ISSN (online) 1096-0295
    ISSN 0273-2300
    DOI 10.1016/j.yrtph.2024.105644
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  8. Artikel ; Online: Strategies for Assessing Acceptable Intakes for Novel

    Ponting, David J / Dobo, Krista L / Kenyon, Michelle O / Kalgutkar, Amit S

    Journal of medicinal chemistry

    2022  Band 65, Heft 23, Seite(n) 15584–15607

    Abstract: The detection ... ...

    Abstract The detection of
    Mesh-Begriff(e) Nitrosamines/toxicity ; Amines ; Pharmaceutical Preparations
    Chemische Substanzen Nitrosamines ; Amines ; Pharmaceutical Preparations
    Sprache Englisch
    Erscheinungsdatum 2022-11-28
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 218133-2
    ISSN 1520-4804 ; 0022-2623
    ISSN (online) 1520-4804
    ISSN 0022-2623
    DOI 10.1021/acs.jmedchem.2c01498
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  9. Artikel: Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy.

    Avenoso, Daniele / Serpenti, Fabio / Slonim, Liron Barnea / Bouziana, Styliani / Dazzi, Francesco / Hannah, Guy / Kenyon, Michelle / Mehra, Varun / Kulasekararaj, Austin / Krishamurthy, Pramila / Shah, Mili Naresh / Lionel, Sharon / Pagliuca, Antonio / Potter, Victoria

    Mediterranean journal of hematology and infectious diseases

    2024  Band 16, Heft 1, Seite(n) e2024002

    Abstract: Background: Allogeneic haematopoietic stem-cell transplant is an option, potentially curative, for high-risk acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) patients. Post-transplant cyclophosphamide administration allows for the ... ...

    Abstract Background: Allogeneic haematopoietic stem-cell transplant is an option, potentially curative, for high-risk acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) patients. Post-transplant cyclophosphamide administration allows for the selection of haploidentical donors in patients who are eligible for the procedure but do not have a fully matched donor since it can overcome the HLA barrier. There is still an active debate on whether intensifying the conditioning regimen is necessary with haploidentical donors when peripheral blood stem cells are used as the graft source. Herein, we report our decennial experience of haploidentical stem-cell transplant using peripheral blood stem cells (haplo-PBSC) at King's College Hospital.
    Objectives: The primary objective was to evaluate overall survival (OS) following haplo-PBSC. Secondary objectives were total OS for patients with less than two previous lines of therapy, OS according to cytomegalovirus (CMV) reactivation, incidence of transplant-related mortality (TRM), graft-versus-host disease (GVHD) and GVHD-relapse-free survival (GRFS).
    Results: One-year and three-year total OS were 62% and 43%, respectively, with a median OS of 22 months. One-year and three-year OS for patients with ≤2 and those with >2 previous lines of therapy were 72% and 55%, and 60% and 22%, respectively (p-value=0.04). The median OS in patients with >2 previous and ≤2 lines of therapy was 16 and 49 months, respectively. Cumulative incidence (CI) of relapse was 25% with a median time to relapse of 5 months (range 1 - 38 months).
    Conclusions: Haploidentical haematopoietic stem-cell transplant is potentially curative in chemosensitive AML and MDS and offers a high rate of prolonged remission. Our cohort further confirms the role of consolidative haploidentical transplant in patients in complete remission and highlights that patients with heavily pre-treated disease may not benefit from this strategy.
    Sprache Englisch
    Erscheinungsdatum 2024-01-01
    Erscheinungsland Italy
    Dokumenttyp Journal Article
    ZDB-ID 2674750-9
    ISSN 2035-3006
    ISSN 2035-3006
    DOI 10.4084/MJHID.2024.002
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel: Nutritional aspects in autoimmune diseases undergoing hematopoietic stem cell transplantation: overview and recommendations on behalf of the EBMT ADWP and Nurses Group.

    Gandossi, Chiara / Jessop, Helen / Hahn, Anne / Heininger, Lisa / Henes, Jörg / Radaelli, Alexia Marina / Carmagnola, Anna / Morello, Enrico / Renica, Chiara / Bertulli, Alice / Lazzari, Lorenzo / Kenyon, Michelle / Alexander, Tobias / Domenech, Ariadna / Greco, Raffaella

    Frontiers in nutrition

    2024  Band 11, Seite(n) 1394518

    Abstract: Autoimmune diseases (ADs) represent a heterogeneous group of conditions affecting 5-10% of the global population. In recent decades, hematopoietic stem cell transplant (HSCT), mainly autologous, has been successfully adopted to treat patients affected by ...

    Abstract Autoimmune diseases (ADs) represent a heterogeneous group of conditions affecting 5-10% of the global population. In recent decades, hematopoietic stem cell transplant (HSCT), mainly autologous, has been successfully adopted to treat patients affected by severe/refractory ADs. In this context malnutrition has a detrimental impact on relapse, mortality, infection rate, engraftment, long-term survival, and prolongation of hospitalization. However, in this population, the management of nutrition should be improved since nutritional assessment is partially performed in routine clinical practice. A panel of nurses and physicians from the European Society for Blood and Marrow Transplantation (EBMT) reviewed all available evidence based on current literature and expert practices from centers with extensive experience in HSCT for ADs, on the nutritional management of ADs patients during HSCT procedure. In this context, adequate nutritional status predicts a better response to treatment and improves quality of life. Herein, a systematic and comprehensive monitoring of nutritional status before, during and after HSCT, with adequate nutritional support in the case of ADs patients, in addition to assessing the dietary requirements associated with HSCT has been covered. Moreover, given the singularity of each AD, the underlying disease should be considered for an appropriate approach. The management and evaluation of nutritional status must be carried out by a multidisciplinary team to assess the needs, monitor the effectiveness of each intervention, and prevent complications, especially in complex situations as patients affected by ADs.
    Sprache Englisch
    Erscheinungsdatum 2024-05-09
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Review
    ZDB-ID 2776676-7
    ISSN 2296-861X
    ISSN 2296-861X
    DOI 10.3389/fnut.2024.1394518
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang